Lyme disease: point/counterpoint

References

• Steere AC, Taylor E, McHugh GL, Logigian EL. The overdiagnosis of Lyme disease. J. Am. Med. Assoc. 269, 1812–1816 (1993).
   PubMed Web of Science ®Google Scholar
• Burrascano JJ. The overdiagnosis of Lyme disease. J. Am. Med. Assoc. 270, 2682 (1993).
   Google Scholar
• Knell RJ. Syphilis in renaissance Europe: rapid evolution of an introduced sexually transmitted disease? Proc. R. Soc. Lond. B. Biol. Sci. 271(Suppl. 4), S174–S176 (2004).
   Google Scholar
• Perlman J. AIDS education: whose morality? Weekly Mail 28 March–4 April, 17 (1991).
   PubMedGoogle Scholar
• Kolata G. Lyme disease is hard to catch and easy to halt, study finds. New York Times 13 June (2001).
   Google Scholar
• Meek JI, Roberts CL, Smith EV, Cartter ML. Underreporting of Lyme disease by Connecticut physicians, 1992. J. Public Health Manage. Pract. 2, 61–65 (1996).
   PubMedGoogle Scholar
• Lautin A, McNeil EL, Liegner KB, Stricker RB, Sigal LH. Lyme disease controversy: use and misuse of language. Ann. Intern. Med. 137, 775–777 (2002).
   PubMedGoogle Scholar
• Bakken LK, Case KL, Callister SM, Bourdeau NJ, Schell RF. Performance of 45 laboratories participating in a proficiency testing program for Lyme disease serology. J. Am. Med. Assoc. 268, 891–895 (1992).
   PubMed Web of Science ®Google Scholar
• Brown SL, Hanson SL, Langone JJ. Role of serology in the diagnosis of Lyme disease. J. Am. Med. Assoc. 282, 62–66 (1999).
   PubMed Web of Science ®Google Scholar
• Montgomery RR, Nathanson MH, Malawista SE. The fate of Borrelia burgdorferi, the agent for Lyme disease, in mouse macrophages. Destruction, survival, recovery. J. Immunol. 150, 909–915 (1993).
   PubMed Web of Science ®Google Scholar
• Bockenstedt LK, Mao J, Hodzic E, Barthold SW, Fish D. Detection of attenuated, noninfectious spirochetes in Borrelia burgdorferi-infected mice after antibiotic treatment. J. Infect. Dis. 186, 1430–1437 (2002).
   PubMed Web of Science ®Google Scholar
• Straubinger RK, Summers BA, Chang YF, Appel MJ. Persistence of Borrelia burgdorferi in experimentally infected dogs after antibiotic treatment. J. Clin. Microbiol. 35, 111–116 (1997).
   PubMed Web of Science ®Google Scholar
• Straubinger RK. PCR-based quantification of Borrelia burgdorferi organisms in canine tissues over a 500-day postinfection period. J. Clin. Microbiol. 38, 2191–2199 (2000).
   PubMed Web of Science ®Google Scholar
• Cadavid D, O’Neill T, Schaefer H, Pachner AR. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab. Invest. 80, 1043–1054 (2000).
   PubMed Web of Science ®Google Scholar
• Preac-Mursic V, Weber K, Pfister HW et al. Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis. Infection 17, 355–359 (1989).
   PubMed Web of Science ®Google Scholar
• Frey M, Jaulhac B, Piemont Y et al. Detection of Borrelia burgdorferi DNA in muscle of patients with chronic myalgia related to Lyme disease. Am. J. Med. 104, 591–594 (1998).
   PubMed Web of Science ®Google Scholar
• Oksi J, Marjamaki M, Nikoskelainen J et al. Borrelia burgdorferi detected by culture and PCR in clinical relapse of disseminated Lyme borreliosis. Ann. Med. 31, 225–232 (1999).
   PubMed Web of Science ®Google Scholar
• Stricker RB, McNeil EL. Duration of antibiotic therapy for Lyme disease. Ann. Intern. Med. 140, W6 (2004).
   Google Scholar
• Steere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J, Nepom GT. Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis. Arthritis Rheum. 48, 534–5340 (2003).
   PubMedGoogle Scholar
• Kalish RS, Wood JA, Golde W et al. Human T lymphocyte response to Borrelia burgdorferi infection: no correlation between human leukocyte function antigen Type 1 peptide response and clinical status. J. Infect. Dis. 187, 102–108 (2003).
   PubMed Web of Science ®Google Scholar
• Stricker RB. Lyme disease: a potential polymicrobial infection. ASM News 69, 265 (2003).
   Google Scholar
• Benach JL, Coleman JL, Habicht GS, MacDonald A, Grunwaldt E, Giron JA. Serological evidence for simultaneous occurrences of Lyme disease and babesiosis. J. Infect. Dis. 152, 473–477 (1985).
   PubMed Web of Science ®Google Scholar
• Marcus LC, Steere AC, Duray PH, Anderson AE, Mahoney EB. Fatal pancarditis in a patient with coexistent Lyme disease and babesiosis. Demonstration of spirochetes in the myocardium. Ann. Intern. Med. 103, 374–376 (1985).
   PubMed Web of Science ®Google Scholar
• Nadelman RB, Horowitz HW, Hsieh TC et al. Simultaneous human granulocytic ehrlichiosis and Lyme borreliosis. N. Engl. J. Med. 337, 27–30 (1997).
   PubMed Web of Science ®Google Scholar
• DeMartino SJ, Carlyon JA, Fikrig E. Coinfections with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis. N. Engl. J. Med. 345, 150–151 (2001).
   PubMed Web of Science ®Google Scholar
• Krause PJ, McKay K, Thompson CA et al. Disease-specific diagnosis of coinfecting tickborne zoonoses: babesiosis, human granulocytic ehrlichiosis, and Lyme disease. Clin. Infect. Dis. 34, 1184–1191 (2002).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Harris NS, Yong DC, Winger EE. Clinical and seroepidemiologic characteristics of Babesia WA-1 coinfection in patients with Lyme disease in California. J. Invest. Med. 51(Suppl. 1), S145 (2003).
   Google Scholar
• Eskow E, Rao RV, Mordechai E. Concurrent infection of the central nervous system by Borrelia burgdorferi and Bartonella henselae: evidence for a novel tick-borne disease complex. Arch. Neurol. 58, 1357–1363 (2001).
   PubMed Web of Science ®Google Scholar
• Holden K, Boothby JT, Anand S, Massung RF. Detection of Borrelia burgdorferi, Ehrlichia chafeensis, and Anaplasma phagocytophilum in ticks (Acari: Ixodidae) from a coastal region of California. J. Med. Entomol. 40, 534–539 (2003).
   PubMedGoogle Scholar
• Burgess EC, Amundson TE, Davis JP, Kaslow RA, Edelman R. Experimental inoculation of Peromyscus spp. with Borrelia burgdorferi: evidence of contact transmission. Am. J. Trop. Med. Hyg. 35, 355–359 (1986).
   PubMed Web of Science ®Google Scholar
• Wright SD, Nielsen SW. Experimental infection of the white-footed mouse with Borrelia burgdorferi. Am. J. Vet. Res.. 51, 1980–1987 (1990).
   PubMed Web of Science ®Google Scholar
• Harvey WT, Salvato P. ‘Lyme disease’: ancient engine of an unrecognized borreliosis pandemic? Med. Hypoth. 60, 742–759 (2003).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Moore DH, Winger EE. Clinical and immunologic evidence for transmission of Lyme disease through intimate human contact. J. Invest. Med. 52, S151 (2004).
   Web of Science ®Google Scholar
• Pavia CS. Current and novel therapies for Lyme disease. Expert Opin. Investig. Drugs12(10),1003–1016 (2003).
   Google Scholar
• Hengge UR, Tannapfel A, Tyring SK, Erbel R, Arendt G, Ruzicka T. Lyme borreliosis. Lancet Infect. Dis.3,489–500 (2003).
   PubMed Web of Science ®Google Scholar
• Wormser GP, Nadelman RB, Dattwyler RJ et al. Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America. Clin. Infect. Dis. 31(Suppl. 1), 1–14 (2000).
   PubMed Web of Science ®Google Scholar
• The ILADS Working Group. Evidence-based guidelines for the management of Lyme disease. Expert Rev. Anti Infect. Ther. 2(1), S1–S13 (2004).
   PubMedGoogle Scholar
• Johnson L, Stricker RB. Treatment of Lyme disease: a medicolegal assessment. Expert Rev. Anti Infect. Ther. 2(4), 533–557 (2004).
   PubMedGoogle Scholar
• Stricker RB, Phillips SE. Lyme disease without erythema migrans: cause for concern? Am. J. Med. 115, 72 (2003).
   PubMedGoogle Scholar
• Edlow JA. Erythema migrans. Med. Clin. North Am. 86, 239–260 (2002).
   PubMedGoogle Scholar
• Schoeler GB, Wikel SK. Modulation of host immunity by haematophagous arthropods. Ann. Trop. Med. Parasitol. 95, 755–771 (2001).
   PubMed Web of Science ®Google Scholar
• Hannier S, Liversidge J, Sternberg JM, Bowman AS. Ixodes ricinus tick salivary gland extract inhibits IL-10 secretion and CD69 expression by mitogen-stimulated murine splenocytes and induces hyporesponsiveness in B lymphocytes. Parasite Immunol. 25, 27–37 (2003).
   PubMed Web of Science ®Google Scholar
• Rhen M, Eriksson S, Clements M, Bergstrom S, Normark SJ. The basis of persistent bacterial infections. Trends Microbiol. 11, 80–86 (2003).
   PubMed Web of Science ®Google Scholar
• Liang FT, Jacobs MB, Bowers LC, Philipp MT. An immune evasion mechanism for spirochetal persistence in Lyme borreliosis. J. Exp. Med. 195, 415–422 (2002).
   PubMed Web of Science ®Google Scholar
• Guner ES. Complement evasion by the Lyme disease spirochete Borrelia burgdorferi grown in host-derived tissue cocultures: role of fibronectin in complement-resistance. Experientia 52, 364–372 (1996).
   Google Scholar
• Ekerfelt C, Ernerudh J, Forsberg P et al. Lyme borreliosis in Sweden – diagnostic performance of five commercial borrelia serology kits using sera from well-defined patient groups. Acta Pathol. Microbiol. Immunol. Scandinavica 112, 74–78 (2004).
   PubMedGoogle Scholar
• Boltri JM, Hash RB, Vogel RL. Patterns of Lyme disease diagnosis and treatment by family physicians in a southeastern state. J. Commun. Health 27, 395–402 (2002).
   PubMedGoogle Scholar
• Ma B, Christen B, Leung D, Vigo-Pelfrey C. Serodiagnosis of Lyme borreliosis by Western immunoblot: reactivity of various significant antibodies against Borrelia burgdorferi. J. Clin. Microbiol. 30, 370–376 (1992).
   PubMedGoogle Scholar
• Feder HM Jr, Gerber MA, Luger SW, Ryan RW. Persistence of serum antibodies to Borrelia burgdorferi in patients treated for Lyme disease. Clin. Infect. Dis. 15, 788–793 (1992).
   PubMed Web of Science ®Google Scholar
• Lane RS, Steinlein DB, Mun J. Human behaviors elevating exposure to Ixodes pacificus (Acari: Ixodidae) nymphs and their associated bacterial zoonotic agents in a hardwood forest. J. Med. Entomol. 41, 239–248 (2004).
   PubMedGoogle Scholar
• Zore A, Ruzic-Sabljic E, Maraspin V et al. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans. Wien Klin. Wochenschr. 114, 606–609 (2002).
   PubMed Web of Science ®Google Scholar
• Liveris D, Wang G, Girao G et al. Quantitative detection of Borrelia burgdorferi in 2-millimeter skin samples of Erythema migrans lesions: correlation of results with clinical and laboratory findings. J. Clin. Microbiol. 40, 1249–1253 (2002).
   PubMed Web of Science ®Google Scholar
• Hicks CB. Confronting the clinical uncertainty regarding syphilis. AIDS Clin. Care 15, 64–65 (2003).
   PubMedGoogle Scholar
• Bruck DK, Talbot ML, Cluss RG, Boothby JT. Ultrastructural characterization of the stages of spheroplast preparation of Borrelia burgdorferi. J. Microbiol. Methods 23, 219–228 (1995).
   Web of Science ®Google Scholar
• Preac-Mursic V, Wanner G, Reinhardt S, Wilske B, Busch U, Marget W. Formation and cultivation of Borrelia burgdorferi spheroplast L-form variants. Infection 24, 218–226 (1996).
   PubMed Web of Science ®Google Scholar
• Alban PS, Johnson PW, Nelson DR. Serum-starvation-induced changes in protein synthesis and morphology of Borrelia burgdorferi. Microbiology 146(Pt 1), 119–127 (2000).
   Google Scholar
• Brorson O, Brorson SH. A rapid method for generating cystic forms of Borrelia burgdorferi, and their reversal to mobile spirochetes. Acta Pathol. Microbiol. Immunol. Scandinavica 106, 1131–1141 (1998).
   PubMed Web of Science ®Google Scholar
• Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to metronidazole. Acta Pathol. Microbiol. Immunol. Scandinavica 107, 566–576 (1999).
   PubMed Web of Science ®Google Scholar
• Kersten A, Poitschek C, Rauch S, Aberer E. Effects of penicillin, ceftriaxone, and doxycycline on the morphology of Borrelia burgdorferi. Antimicrob. Agents Chemother. 39, 1127–1133 (1995).
   PubMed Web of Science ®Google Scholar
• Aberer E, Koszik F, Silberer M. Why is chronic Lyme borreliosis chronic? Clin. Infect. Dis. 25(Suppl. 1), S64–S70 (1997).
   Google Scholar
• Porcella SF, Schwan TG. Borrelia burgdorferi and Treponema pallidum: a comparison of functional genomics, environmental adaptations, and pathogenic mechanisms. J. Clin. Invest. 107, 651–656 (2001).
   PubMedGoogle Scholar
• Casjens S, Palmer N, van Vugt R et al. A bacterial genome in flux: the twelve linear and nine circular extrachromosomal DNAs in an infectious isolate of the Lyme disease spirochete Borrelia burgdorferi. Mol. Microbiol. 35, 490–516 (2000).
   PubMed Web of Science ®Google Scholar
• Kraiczy P, Hellwage J, Skerka C et al. Complement resistance of Borrelia burgdorferi correlates with expression of BbCRASP-1, a novel linear plasmid-encoded surface protein that interacts with human factor H and FHL-1 and is unrelated to Erp proteins. J. Biol. Chem. 279, 2421–2429 (2004).
   PubMed Web of Science ®Google Scholar
• Zhang H, Raji A, Theisen M, Hansen PR, Marconi RT. BdrF2 of Lyme disease spirochetes is coexpressed with a series of cytoplasmic proteins and is produced specifically during early infection. J. Bacteriol. 187, 175–184 (2005).
   PubMedGoogle Scholar
• Liang FT, Brown EL, Wang T, Iozzo RV, Fikrig E. Protective niche for Borrelia burgdorferi to evade humoral immunity. Am. J. Pathol. 165, 977–985 (2004).
   PubMed Web of Science ®Google Scholar
• Liang FT, Yan J, Mbow ML et al. Borrelia burgdorferi changes its surface antigenic expression in response to host immune responses. Infect. Immun. 72, 5759–5767 (2004).
   PubMedGoogle Scholar
• Qiu WG, Schutzer SE, Bruno JF et al. Genetic exchange and plasmid transfers in Borrelia burgdorferi sensu stricto revealed by three-way genome comparisons and multilocus sequence typing. Proc. Natl Acad. Sci. USA 101, 14150–14155 (2004).
   PubMed Web of Science ®Google Scholar
• Stewart PE, Hoff J, Fischer E, Krum JG, Rosa PA. Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants. Appl. Environ. Microbiol. 70, 5973–5979 (2004).
   PubMedGoogle Scholar
• Grimm D, Eggers CH, Caimano MJ et al. Experimental assessment of the roles of linear plasmids lp25 and lp28–1 of Borrelia burgdorferi throughout the infectious cycle. Infect. Immun. 72, 5938–5946 (2004).
   PubMedGoogle Scholar
• Cluss RG, Silverman DA, Stafford TR. Extracellular secretion of the Borrelia burgdorferi Oms28 porin and Bgp, a glycosaminoglycan binding protein. Infect. Immun. 72, 6279–6286 (2004).
   PubMedGoogle Scholar
• Grab DJ, Perides G, Dumler JS et al. Borrelia burgdorferi, host-derived proteases, and the blood–brain barrier. Infect. Immun. 73, 1014–1022 (2005).
   PubMed Web of Science ®Google Scholar
• Terekhova D, Sartakova ML, Wormser GP, Schwartz I, Cabello FC. Erythromycin resistance in Borrelia burgdorferi. Antimicrob. Agents Chemother. 46, 3637–3640 (2002).
   PubMed Web of Science ®Google Scholar
• Ma Y, Sturrock A, Weis JJ. Intracellular localization of Borrelia burgdorferi within human endothelial cells. Infect. Immun. 59, 671–678 (1991).
   PubMed Web of Science ®Google Scholar
• Klempner MS, Noring R, Rogers RA. Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J. Infect. Dis. 167, 1074–1081 (1993).
   PubMed Web of Science ®Google Scholar
• Girschick HJ, Huppertz HI, Russmann H, Krenn V, Karch H. Intracellular persistence of Borrelia burgdorferi in human synovial cells. Rheumatol. Intl 16, 125–130 (1996).
   PubMed Web of Science ®Google Scholar
• Linder S, Heimerl C, Fingerle V, Aepfelbacher M, Wilske B. Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Rac1 and involves recruitment of Wiskott–Aldrich syndrome protein and Arp2/3 complex. Infect. Immun. 69, 1739–1746 (2001).
   PubMed Web of Science ®Google Scholar
• Georgilis K, Peacocke M, Klempner MS. Fibroblasts protect the Lyme disease spirochete, Borrelia burgdorferi, from ceftriaxone in vitro. J. Infect. Dis. 166, 440–444 (1992).
   PubMed Web of Science ®Google Scholar
• Brouqui P, Badiaga S, Raoult D. Eukaryotic cells protect Borrelia burgdorferi from the action of penicillin and ceftriaxone but not from the action of doxycycline and erythromycin. Antimicrob. Agents Chemother. 40, 1552–1554 (1996).
   PubMed Web of Science ®Google Scholar
• Embers ME, Ramamoorthy R, Philipp MT. Survival strategies of Borrelia burgdorferi, the etiologic agent of Lyme disease. Microbes Infect. 6, 312–318 (2004).
   PubMed Web of Science ®Google Scholar
• Chan J, Flynn J. The immunological aspects of latency in tuberculosis. Clin. Immunol. 110, 2–12 (2004).
   PubMed Web of Science ®Google Scholar
• Mukamolova GV, Turapov OA, Young DI, Kaprelyants AS, Kell DB, Young M. A family of autocrine growth factors in Mycobacterium tuberculosis. Mol. Microbiol. 46, 623–635 (2002).
   PubMed Web of Science ®Google Scholar
• Stevenson B, von Lackum K, Wattier RL, McAlister JD, Miller JC, Babb K. Quorum sensing by the Lyme disease spirochete. Microbes Infect. 5, 991–997 (2003).
   PubMedGoogle Scholar
• Thomas V, Anguita J, Barthold SW, Fikrig E. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis alters murine immune responses, pathogen burden, and severity of Lyme arthritis. Infect. Immun. 69, 3359–3371 (2001).
   PubMed Web of Science ®Google Scholar
• Zeidner NS, Dolan MC, Massung R, Piesman J, Fish D. Coinfection with Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis suppresses IL-2 and IFN gamma production and promotes an IL-4 response in C3H/HeJ mice. Parasite Immunol. 22, 581–588 (2000).
   PubMed Web of Science ®Google Scholar
• Moro MH, Zegarra-Moro OL, Bjornsson J et al. Increased arthritis severity in mice coinfected with Borrelia burgdorferi and Babesia microti. J. Infect. Dis. 186, 428–431 (2002).
   PubMedGoogle Scholar
• Krause PJ, Telford SR 3rd, Spielman A et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. J. Am. Med. Assoc. 275, 1657–1660 (1996).
   PubMed Web of Science ®Google Scholar
• Oleson CV, Sivalingam JJ, O’Neill BJ, Staas WE. Transverse myelitis secondary to coexistent Lyme disease and babesiosis. J. Spinal Cord Med. 26, 168–171 (2003).
   Google Scholar
• Krause PJ, Spielman A, Telford SR et al. Persistent parasitemia after acute babesiosis. N. Engl. J. Med. 339, 160–165 (1998).
   PubMed Web of Science ®Google Scholar
• Allred DR. Babesiosis: persistence in the face of adversity. Trends Parasitol. 19, 51–55 (2003).
   Google Scholar
• Harrus S, Waner T, Aizenberg I, Foley JE, Poland AM, Bark H. Amplification of ehrlichial DNA from dogs 34 months after infection with Ehrlichia canis. J. Clin. Microbiol. 36, 73–76 (1998).
   PubMed Web of Science ®Google Scholar
• Dumler JS, Bakken JS. Human granulocytic ehrlichiosis in Wisconsin and Minnesota: a frequent infection with the potential for persistence. J. Infect. Dis. 173, 1027–1030 (1996).
   PubMedGoogle Scholar
• Chomel BB, Kasten RW, Sykes JE, Boulouis HJ, Breitschwerdt EB. Clinical impact of persistent Bartonella bacteremia in humans and animals. Ann. NY Acad. Sci.990,267–278 (2003).
   PubMedGoogle Scholar
• Nadelman RB, Wormser GP. Single-dose doxycycline for the prevention of Lyme disease. N. Engl. J. Med. 345, 1349–1350 (2001).
   Google Scholar
• Wormser GP, Ramanathan R, Nowakowski J et al. Duration of antibiotic therapy for early Lyme disease. A randomized, double-blind, placebo-controlled trial. Ann. Intern. Med. 138, 697–704 (2003).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Gaito A, Harris NS, Burrascano JJ. Treatment of early Lyme disease. Ann. Intern. Med. 140, 577 (2004).
   PubMedGoogle Scholar
• Klempner MS, Hu LT, Evans J et al. Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 345, 85–92 (2001).
   PubMed Web of Science ®Google Scholar
• Bransfield R, Brand S, Sherr V. Treatment of patients with persistent symptoms and a history of Lyme disease. N. Engl. J. Med. 345, 1424–1425 (2001).
   PubMedGoogle Scholar
• Fallon BA. Laboratory findings in chronic Lyme disease and results of a controlled treatment study. Presented at the Annual Meeting of the Lyme Disease Association. Rye, NY, USA, 22 October 2004.
   Google Scholar
• Nocton JJ, Dressler F, Rutledge BJ, Rys PN, Persing DH, Steere AC. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in synovial fluid in Lyme arthritis. N. Engl. J. Med. 330, 229–234 (1994).
   PubMed Web of Science ®Google Scholar
• Nocton JJ, Bloom BJ, Rutledge BJ et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in patients with Lyme neuroborreliosis. J. Infect. Dis. 174, 623–627 (1996).
   PubMed Web of Science ®Google Scholar
• Lawrence C, Lipton RB, Lowy FD, Coyle PK. Seronegative chronic relapsing neuroborreliosis. Eur. Neurol. 35, 113–117 (1995).
   PubMed Web of Science ®Google Scholar
• Fraser DD, Kong LI, Miller FW. Molecular detection of persistent Borrelia burgdorferi in a man with dermatomyositis. Clin. Exp. Rheumatol. 10, 387–390 (1992).
   PubMed Web of Science ®Google Scholar
• Burrascano JJ. Lyme disease. In: Conn’s Current Therapy. WB Saunders Company, PA, USA, 140–143 (1997).
   Google Scholar
• Liegner KB, Kochevar J. Guidelines for the clinical diagnosis of Lyme disease. Ann. Intern. Med. 129, 422–423 (1998).
   PubMedGoogle Scholar
• Hanson MS, Edelman R. Progress and controversy surrounding vaccines against Lyme disease. Expert Rev. Vaccines 2(5), 683–703 (2003).
   PubMedGoogle Scholar
• Valenzuela JG. Exploring the messages of the salivary glands of Ixodes ricinus. Am. J. Trop. Med. Hyg. 66(3), 223–224 (2002).
   PubMed Web of Science ®Google Scholar
• Burke G, Wikel SK, Spielman A, Telford SR, McKay K, Krause PJ and the Tick-borne study group. Hypersensitivity to ticks and Lyme disease risk. Emerg. Infect. Dis. 11, 36–41 (2005).
   PubMedGoogle Scholar
• Tsao JI, Wootton JT, Bunikis J, Luna MG, Fish D, Barbour AG. An ecological approach to preventing human infection: vaccinating wild-mouse reservoirs intervenes in the Lyme disease cycle. Proc. Natl Acad. Sci. USA 101, 18159–18164 (2004).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Winger EE. Decreased CD57 lymphocyte subset in patients with chronic Lyme disease. Immunol. Lett. 76, 43–48 (2001).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Burrascano J, Winger EE. Longterm decrease in the CD57 lymphocyte subset in a patient with chronic Lyme disease. Ann. Agric. Environ. Med. 9, 111–113 (2002).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Winger EE. Normalization of the CD57 natural killer cell subset associated with prolonged antibiotic therapy in patients with chronic Lyme disease. Clin. Immunol. 103, S117–S118 (2002).
   Google Scholar
• Brorson O, Brorson SH. An in vitro study of the susceptibility of mobile and cystic forms of Borrelia burgdorferi to tinidazole. Intl Microbiol. 7, 139–142 (2004).
   PubMed Web of Science ®Google Scholar
• Hunfeld KP, Wichelhaus TA, Rodel R, Acker G, Brade V, Kraiczy P. Comparison of in vitro activities of ketolides, macrolides, and an azalide against the spirochete Borrelia burgdorferi. Antimicrob. Agents Chemother. 48, 344–347 (2004).
   PubMed Web of Science ®Google Scholar
• Stricker RB, Thomas SL, Moore DH, Winger EE. Efficacy of clarithromycin/cefdinir combination therapy in patients with chronic Lyme disease. J. Invest. Med. 53, S156 (2005).
   Google Scholar
• Widhe M, Grusell M, Ekerfelt C, Vrethem M, Forsberg P, Ernerudh J. Cytokines in Lyme borreliosis: lack of early TNF α and TGF β 1 responses are associated with chronic neuroborreliosis. Immunology 107, 46–55 (2002).
   PubMedGoogle Scholar
• Widhe M, Jarefors S, Ekerfelt C et al. Borrelia specific IFN-γ and IL-4 secretion in blood and CSF during the course of human Lyme borreliosis: relation to clinical outcome. J. Infect. Dis. 189, 1881–1891 (2004).
   PubMed Web of Science ®Google Scholar
• Fallon BA, Das S, Plutchok JJ, Tager F, Liegner K, Van Heertum R. Functional brain imaging and neuropsychological testing in Lyme disease. Clin. Infect. Dis. 25(Suppl. 1), S57–S63 (1997).
   Google Scholar
• Liegner KB, Duray P, Agricola M et al. Lyme disease and the clinical spectrum of antibiotic responsive chronic meningoencephalomyelitides. J. Spiro. Tick Dis. 4, 61–73 (1997).
   Google Scholar
• Small PM, Fujiwara PI. Management of tuberculosis in the USA. N. Engl. J. Med. 345, 189–200 (2001).
   PubMed Web of Science ®Google Scholar
• Shaw IN, Natrajan MM, Rao GS, Jesudasan K, Christian M, Kavitha M. Long-term follow-up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of 2 years. Int. J. Lepr. Other Mycobact. Dis. 68, 405–409 (2000).
   PubMedGoogle Scholar
• Goto M. Chemotherapy of leprosy: theoretical basis of new guideline in Japan. Nihon Hansenbyo Gakkai Zasshi70,151–155 (2001).
   PubMedGoogle Scholar
• Wallace RJ Jr, Tanner D, Brennan PJ, Brown BA. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae. Ann. Intern. Med. 119, 482–486 (1993).
   PubMed Web of Science ®Google Scholar
• Rolain JM, Mallet MN, Raoult D. Correlation between serum doxycycline concentrations and serologic evolution in patients with Coxiella burnetii endocarditis. J. Infect. Dis. 188, 1322–1325 (2003).
   PubMedGoogle Scholar